share_log

CBD Life Sciences, Inc. (CBDL) Looking to Expand Its Brand Into Retail Stores Nationwide

CBD Life Sciences, Inc. (CBDL) Looking to Expand Its Brand Into Retail Stores Nationwide

CBD生命科學公司(CBDL)計劃將其品牌擴展到全國零售店。
Accesswire ·  06/27 08:00

SCOTTSDALE, AZ / ACCESSWIRE / June 27, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, The CBD Vault Inc. a leading innovator in the CBD industry, is thrilled to announce its strategic initiative to expand its brand into retail stores nationwide. This expansion aims to bring our premium CBD products to a wider audience, enhancing accessibility and driving growth in the burgeoning CBD market.

亞利桑那州斯科茨代爾/ACCESSWIRE/2024年6月27日/CBD Life Sciences Inc.(場外交易鏈接:CBDL)通過其全資子公司CBD Vault Inc.是CBD行業的領先創新者,很高興地宣佈其戰略計劃,將其品牌擴展到全國零售門店。此次擴張旨在將我們的優質CBD產品帶給更廣泛的受衆,提高可及性並推動蓬勃發展的CBD市場的增長。

Exploring Opportunities with Retail Giants, Hotels, and Sports Teams

與零售巨頭、酒店和運動隊一起探索機遇

CBDL is currently exploring potential partnerships with several prominent retail chains, including Sprouts Farmers Market, Whole Foods Market, Walgreens, and CVS Pharmacy. Additionally, we are in preliminary discussions with major hotel chains and professional sports teams. While these discussions are in the early stages, we are optimistic about the possibilities these collaborations could bring. By securing placements in these high-traffic venues, CBDL aims to significantly increase its market presence and brand recognition.

CBDL目前正在探索與幾家知名零售連鎖店的潛在合作伙伴關係,包括Sprouts Farmers Market、Whole Foods Market、Walgreens和CVS Pharmacy。此外,我們正在與主要連鎖酒店和職業運動隊進行初步討論。儘管這些討論還處於初期階段,但我們對這些合作可能帶來的可能性持樂觀態度。通過確保這些高流量場所的安置權,CBDL旨在顯著提高其市場佔有率和品牌知名度。

Projected Growth and Revenue Potential

預計增長和收入潛力

The expansion into retail stores is projected to drive substantial revenue growth. Our market research indicates that the CBD industry is expected to grow at a compound annual growth rate (CAGR) of 22.2% over the next five years. With our entry into these larger retail channels, we anticipate a potential revenue increase of up to 150% in the first year alone.

預計向零售商店的擴張將推動收入的大幅增長。我們的市場研究表明,預計未來五年CBD行業將以22.2%的複合年增長率(CAGR)增長。隨着我們進入這些更大的零售渠道,我們預計僅在第一年就可能實現高達150%的收入增長。

Expansion and Product Availability

擴展和產品可用性

In addition to engaging with retail giants, hotels, and sports teams, CBDL is exploring opportunities with regional and local retailers to ensure comprehensive market coverage. This multi-faceted approach will allow us to reach a diverse customer base, from health-conscious shoppers at Whole Foods to convenience-seeking consumers at Walgreens and CVS, as well as guests at hotels and sports enthusiasts.

除了與零售巨頭、酒店和運動隊合作外,CBDL還在與區域和本地零售商一起探索機會,以確保全面的市場覆蓋。這種多方面的方法將使我們能夠接觸到多元化的客戶群,從Whole Foods注重健康的購物者到沃爾格林和CVS尋求便利的消費者,以及酒店的客人和體育愛好者。

Commitment to Quality and Customer Satisfaction

對質量和客戶滿意度的承諾

As we expand, CBDL remains committed to maintaining the highest standards of product quality and customer satisfaction. Our products are crafted using the finest ingredients, rigorously tested for purity and potency, and designed to deliver the best possible CBD experience. We believe that our dedication to quality will resonate with consumers and drive repeat business.

隨着我們的擴張,CBDL仍然致力於保持產品質量和客戶滿意度的最高標準。我們的產品採用最優質的原料製成,經過嚴格的純度和效力測試,旨在提供最佳的CBD體驗。我們相信,我們對質量的追求將引起消費者的共鳴並推動回頭客。

Investing in Our Future

投資我們的未來

To support this expansion, CBDL is also investing in our production capabilities and supply chain efficiency. We are enhancing our manufacturing processes to meet the increased demand and ensure timely delivery of our products to retail partners. These investments are crucial to sustaining our growth and maintaining our reputation for excellence.

爲了支持這種擴張,CBDL還投資於我們的生產能力和供應鏈效率。我們正在改進我們的製造流程,以滿足不斷增長的需求,並確保我們的產品及時交付給零售合作伙伴。這些投資對於維持我們的增長和保持我們的卓越聲譽至關重要。

Looking Ahead

展望未來

CBDL's expansion into retail stores nationwide represents a significant milestone in our journey. We are confident that this strategic move will not only boost our revenue but also solidify our position as a leader in the CBD industry. We appreciate the continued support of our shareholders and look forward to sharing more exciting developments in the near future.

CBDL向全國零售商店的擴張是我們旅程中的一個重要里程碑。我們相信,這一戰略舉措不僅將增加我們的收入,還將鞏固我們在CBD行業的領導者地位。我們感謝股東的持續支持,並期待在不久的將來分享更多令人興奮的進展。

About The CBD Vault Inc.

關於 CBD Vault Inc.

The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets. The CBD Vault's products can be viewed and purchased on the Company's website at

CBD Vault Inc.是CBD Life Sciences Inc.的全資子公司。CBD Vault開發並零售/批發了全系列的大麻二酚類有機產品,包括CBD滴劑、止痛霜、焦慮和睡眠補充劑、食品、咖啡、護膚系列、寵物系列、平板電腦。可以在公司的網站上查看和購買CBD Vault的產品,網址爲

Follow our social media for the latest updates!

關注我們的社交媒體,了解最新動態!

X:

X:

Instagram:

Instagram

IR Contact: cbdvaultaz@gmail.com

投資者關係聯繫人:cbdvaultaz@gmail.com

Forward-Looking Statements

前瞻性陳述

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

除此處包含的歷史信息外,本新聞稿中討論的事項均爲前瞻性陳述。實際結果可能與前瞻性陳述中描述的結果存在重大差異,並且受風險和不確定性的影響。參見 CBD 生命科學公司'向場外交易市場提交的文件,這些文件可能會確定可能導致實際業績或事件與前瞻性陳述中描述的結果或事件存在重大差異的具體因素。

Safe Harbor Statement

安全港聲明

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

本新聞稿包括前瞻性陳述,這些陳述基於某些假設,反映了管理層當前的預期。這些前瞻性陳述受到許多風險和不確定性的影響,這些風險和不確定性可能導致實際結果或事件與當前的預期存在重大差異。其中一些因素包括:全球總體經濟狀況;總體行業和市場狀況、行業變化和增長率;我們的戰略和業務計劃能否產生預期收益的不確定性;競爭加劇;資本的可用性和成本;識別和發展並取得商業成功的能力;維持和改善服務質量所需的支出水平;經濟的變化;法律和法規的變化,包括守則和標準、知識產權和稅收事項;或其他意料之外的事項;我們保護和維持戰略關係和分銷協議的能力。公司不打算或義務更新或修改任何前瞻性能力,以保護和維持戰略關係和分銷協議。公司不表示有任何更新或修改任何前瞻性陳述的意圖或義務。

SOURCE: CBD Life Sciences Inc.

來源:CBD 生命科學公司


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論